Wu Yong-Jin, Meanwell Nicholas A
Small Molecule Drug Discovery, Bristol Myers Squibb Research and Early Development, 100 Binney Street, Cambridge, Massachusetts 02142, United States.
Department of Discovery and Chemistry and Molecular Technologies, Bristol-Myers Squibb PRI, PO Box 4000, Princeton, New Jersey 08543-4000, United States.
J Med Chem. 2021 Jul 22;64(14):9786-9874. doi: 10.1021/acs.jmedchem.1c00790. Epub 2021 Jul 2.
Acetals and ketals and their nitrogen and sulfur homologues are often considered to be unconventional and potentially problematic scaffolding elements or pharmacophores for the design of orally bioavailable drugs. This opinion is largely a function of the perception that such motifs might be chemically unstable under the acidic conditions of the stomach and upper gastrointestinal tract. However, even simple acetals and ketals, including acyclic molecules, can be sufficiently robust under acidic conditions to be fashioned into orally bioavailable drugs, and these structural elements are embedded in many effective therapeutic agents. The chemical stability of molecules incorporating geminal diheteroatomic motifs can be modulated by physicochemical design principles that include the judicious deployment of proximal electron-withdrawing substituents and conformational restriction. In this Perspective, we exemplify geminal diheteroatomic motifs that have been utilized in the discovery of orally bioavailable drugs or drug candidates against the backdrop of understanding their potential for chemical lability.
缩醛、缩酮及其氮和硫的同系物通常被认为是用于设计口服生物利用度药物的非常规且可能有问题的骨架元素或药效基团。这种观点很大程度上源于这样一种认知,即此类结构单元在胃和上消化道的酸性条件下可能化学不稳定。然而,即使是简单的缩醛和缩酮,包括无环分子,在酸性条件下也能足够稳定,从而被制成口服生物利用度药物,并且这些结构元素存在于许多有效的治疗药物中。包含偕二杂原子结构单元的分子的化学稳定性可通过物理化学设计原则来调节,这些原则包括合理部署近端吸电子取代基和构象限制。在本综述中,我们在理解偕二杂原子结构单元化学不稳定性潜力的背景下,举例说明了在口服生物利用度药物或候选药物发现中所使用的偕二杂原子结构单元。